Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on August 31, 2006.
Experimental Physiology (2006)
DOI: 10.1113/expphysiol.2006.034736
© The Physiological Society 2006

A more recent version of this article appeared on January 1, 2007
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
92/1/207    most recent
expphysiol.2006.034736v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Carola U Niesler
Kathryn H Myburgh
Frances Moore
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niesler, C. U
Right arrow Articles by Moore, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niesler, C. U
Right arrow Articles by Moore, F.

Received June 20, 2006
Revised August 4, 2006
Accepted after revision August 29, 2006


Muscle [260]

The changing AMPK expression profile in differentiating skeletal muscle myoblast cells helps confer increasing resistance to apoptosis

Carola U Niesler 1, Kathryn H Myburgh 1, Frances Moore 2*

1 Stellenbosch University
2 University of Stellenbosch

* To whom correspondence should be addressed. E-mail: frances.moore{at}horm.ucl.ac.be.


   Abstract
Abstract AMP-activated protein kinase (AMPK) functions as a {alpha}/{beta}/{gamma} heterotrimer to preserve ATP levels and so cell viability during stressful conditions. However its role in aiding survival of adult skeletal muscle precursor cells is unclear. Using the differentiating mouse C2C12 postnatal skeletal muscle myoblast cell line we have determined that proteins for the AMPK subunit isoforms {alpha}2 and {gamma}2 are constitutively expressed while those for {alpha}1, {beta}1 and {beta}2 are undetectable in undifferentiated myoblasts but increasingly expressed with differentiation to myotubes. Although the {gamma}3 subunit is expressed at a low level in myoblasts it too is increasingly expressed with differentiation to myotubes. The p50 but not the p72 isoform of the embryonic {alpha} subunit homologue MELK is expressed only in proliferating myoblasts while the ARK5 {alpha} subunit homologue is increasingly expressed with differentiation. Myotubes displayed higher basal and stimulated {alpha}1/{alpha}2 AMPK activation than myoblasts. Furthermore, serum starvation resulted in less apoptosis of differentiated myotubes than undifferentiated myoblasts. This reflects, in part, their increased expression of functional AMPK since specific inhibition of AMPK activity with Compound C exacerbated the apoptosis due to serum withdrawal. If these in vitro events also occur in vivo then they could have implications for pathologies such as muscle wasting where undifferentiated satellite stem cells may be easier apoptotic targets than their differentiated counterparts. Further, these results suggest that when interpreting results from in vitro or in vivo experiments on AMPK the subunit expression profile should be taken into account.

Key Words: Energy, Myoblast, Protein kinase







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the The Physiological Society.